- Home
- MTNB vs IPST Comparison
MTNB vs IPST Comparison
Compare MTNB & IPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTNB | IPST |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 3.0M |
| IPO Year | 2014 | 2024 |
Fundamental Metrics
Financial Performance| Metric | MTNB | IPST |
|---|---|---|
| Price | $1.39 | $2.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 68.6K | ★ 975.3K |
| Earning Date | 08-13-2026 | 10-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.84 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $119,750.00 | ★ $8,402,488.00 |
| Revenue This Year | N/A | $66.82 |
| Revenue Next Year | N/A | $60.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 5.41 |
| 52 Week Low | $0.15 | $0.26 |
| 52 Week High | $3.16 | $301.60 |
Technical Indicators
Market Signals| Indicator | MTNB | IPST |
|---|---|---|
| Relative Strength Index (RSI) | 40.61 | 40.92 |
| Support Level | $0.56 | $2.22 |
| Resistance Level | $3.16 | $2.80 |
| Average True Range (ATR) | 0.25 | 0.37 |
| MACD | -0.14 | 0.03 |
| Stochastic Oscillator | 22.97 | 17.78 |
Price Performance
Historical ComparisonAbout MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
About IPST Heritage Distilling Holding Company Inc.
IP Strategy Holdings Inc operate a diversified business centered on digital asset-based infrastructure and intellectual property (IP) management, supplemented by a legacy craft spirits operating segment. The Company provides public market investors with broad exposure to the around $80 trillion programmable intellectual property economy in a regulated equity format. Its treasury reserve of $IP tokens provides direct participation in the Story ecosystem, which enables on-chain registration, licensing, and monetization of intellectual property.